Mechanical Circulatory Support in the Treatment of Advanced Heart Failure

Механическая поддержка кровообращения в лечении прогрессирующей сердечной недостаточности
Howard J. Eisen, Amanda Wen Cai, Sabrina Islam, Shelley R. Hankins, W. Fischer
2017-06-22

Advanced heart failureDurable MCS devicesEnd-stage heart failureHeart transplantationMechanical circulatory support
According to the Centers for Disease Control, heart failure (HF) remains a pervasive condition with high morbidity and mortality, affecting 5.8 million people in the United States and 23 million worldwide. For patients with refractory end-stage HF, heart transplantation is the "gold standard" for definitive treatment. However, the demand for heart transplantation has consistently exceeded the availability of donor hearts, with approximately 2331 orthotopic heart transplantations performed in the United States in 2015 despite an estimated 100 000 to 250 000 patients with New York Heart Association class IIIB or IV symptoms that are refractory to medical treatment, making such patients potential transplant candidates. As such, the need for mechanical circulatory support (MCS) to treat patients with end-stage HF has become paramount. In this review, we focus on the history, advancements, and current use of durable MCS device therapy in the treatment of advanced heart failure.
1
Heart failure affects approximately 5.8 million people in the United States and 23 million worldwide, with substantial morbidity and mortality.
2
Heart transplantation remains the definitive treatment for refractory end-stage heart failure, but donor-heart availability is insufficient.
3
In 2015, approximately 2,331 orthotopic heart transplantations were performed in the United States despite an estimated 100,000–250,000 patients with refractory NYHA class IIIB or IV symptoms.
4
The persistent mismatch between transplant demand and donor supply makes durable mechanical circulatory support increasingly important for advanced heart failure.
5
The review examines the history, technological advances, and current clinical use of durable mechanical circulatory support devices.

durable mechanical circulatory support devices for patients with advanced or end-stage heart failure

the history, technological advancements, and current clinical use of durable mechanical circulatory support device therapy for treating advanced heart failure

Publication Details
Publication Date
2017-06-22
Journal
Publisher
ISSN
Cited by
35
Access Type
Author Information
Authors
Howard J. Eisen
Amanda Wen Cai
Sabrina Islam
Shelley R. Hankins
W. Fischer
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%